SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001437749-19-024983
Filing Date
2019-12-30
Accepted
2019-12-30 10:07:21
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM 424B3 dffn20191226_424b3.htm 424B3 237984
2 logo01.jpg GRAPHIC 10140
3 logo.jpg GRAPHIC 26138
  Complete submission text file 0001437749-19-024983.txt   289448
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-235670 | Film No.: 191315173
SIC: 2834 Pharmaceutical Preparations